Publication | Closed Access
Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis.
60
Citations
0
References
2002
Year
The results suggest that antiangiogenesis treatment using endostatin represents a potential new therapeutic strategy for RA.